Citius Pharmaceuticals Inc (NYSE: CTXR) — Healthcare · Share Price, Chart & Market Data
About: Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.77 (-17.47%)
CTXRCitius Pharmaceuticals Inc
Loading watchlist status…
Trade CTXR now
Citius Pharmaceuticals Inc share price
CTXR price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:38 am GMT+0
CTXR price performance
-8.865%
5D
7.093%
1M
-9.198%
YTD
-8.768%
1Y
CTXR price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:38 am GMT+0
CTXR details
CTXR Market Signals